Search Results 1391-1400 of 20130 for Hepatitis C

  1. Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies - Mayo Clinic

    Ratio (INR) >1.5. 7. Known human immunodeficiency virus, hepatitis B, or active hepatitis C virus infection. 8. Participated in a study of an ...

  2. Publications - Titus C. Evans, Jr., M.D. - Mayo Clinic

    Hynes JK, Smith HC, Holmes DR Jr, Edwards WD, Evans TC Jr, Orszulak TA. Preoperative angiographic diagnosis of primary sarcoma of the pulmonary artery.

  3. Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Known historical or active infection with HIV, hepatitis B, or hepatitis C. Active infection or an unexplained fever > 38.5°C during screening visits or on ...

  4. CAST-AI: Cystectomy after systemic therapy with ADC and Immunotherapy - Mayo Clinic

    * Known active hepatitis B or C infection \[however, participants with history of hepatitis C infection but normal hepatitis C virus polymerase chain ...

  5. Drugs and Supplements that Start with H - Mayo Clinic

    Hepatitis a and hepatitis b vaccine (intramuscular route) ... Hepatitis b immune globulin (intramuscular route, intravenous route) ... Hyate:C. Also known as.

  6. A Study of X4P-001 in Patients with Advanced Renal Cell Carcinoma - Mayo Clinic

    An indeterminate or positive test for antibody to hepatitis C virus (HCV), unless documented to have no detectable viral load on two independent samples; A ...

  7. Elotuzumab In Immunoglobulin G4-Related Disease (IgG4-RD) - Mayo Clinic

    Hepatitis B as indicated by surface antigen or hepatitis B core antibody positivity;; Hepatitis C as indicated by anti-hepatitis C antibody positivity; if a ...

  8. A Phase 1/2 Study To Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Efficacy Of HMB-001 In Glanzmann Thrombasthenia - Mayo Clinic

    Known severe congenital or acquired thrombophilia. 5. Has a positive test for Hepatitis B surface antigen (HbsAg), Hepatitis C antibody (HCV Ab), or human ...

  9. A First-in-Human Study Of YL217 In Patients With Advanced Solid Tumors - Mayo Clinic

    * Active hepatitis C infection. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 10/29/2025. Questions ...

  10. Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    ... hepatitis B virus (HBV) or hepatitis C virus (HCV) infection -Hypervascular liver masses > 2 cm, and either serum alpha-fetoprotein (AFP) > 400 ng/ml -AFP ...